Entera Bio Ltd. Statistics
Share Statistics
Entera Bio Ltd. has 36.83M shares outstanding. The number of shares has increased by 3.81% in one year.
| Shares Outstanding | 36.83M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.4% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 29.74M |
| Failed to Deliver (FTD) Shares | 387 |
| FTD / Avg. Volume | 0.52% |
Short Selling Information
The latest short interest is 61.47K, so 0.17% of the outstanding shares have been sold short.
| Short Interest | 61.47K |
| Short % of Shares Out | 0.17% |
| Short % of Float | 0.21% |
| Short Ratio (days to cover) | 0.42 |
Valuation Ratios
The PE ratio is -1.96 and the forward PE ratio is -3.04.
| PE Ratio | -1.96 |
| Forward PE | -3.04 |
| PS Ratio | 0 |
| Forward PS | 1.8 |
| PB Ratio | 1.68 |
| P/FCF Ratio | -2.38 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Entera Bio Ltd..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.32, with a Debt / Equity ratio of 0.
| Current Ratio | 10.32 |
| Quick Ratio | 10.32 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -0.86% and return on capital (ROIC) is -82.78%.
| Return on Equity (ROE) | -0.86% |
| Return on Assets (ROA) | -0.76% |
| Return on Capital (ROIC) | -82.78% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -522.88K |
| Employee Count | 17 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 29.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 299.2% in the last 52 weeks. The beta is 1.59, so Entera Bio Ltd.'s price volatility has been higher than the market average.
| Beta | 1.59 |
| 52-Week Price Change | 299.2% |
| 50-Day Moving Average | 1.91 |
| 200-Day Moving Average | 1.94 |
| Relative Strength Index (RSI) | 75.09 |
| Average Volume (20 Days) | 74.31K |
Income Statement
| Revenue | n/a |
| Gross Profit | -56.00K |
| Operating Income | -8.89M |
| Net Income | -8.89M |
| EBITDA | -8.80M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.31 |
Balance Sheet
The company has 11.02M in cash and 390.00K in debt, giving a net cash position of 10.63M.
| Cash & Cash Equivalents | 11.02M |
| Total Debt | 390.00K |
| Net Cash | 10.63M |
| Retained Earnings | -104.39M |
| Total Assets | 7.74M |
| Working Capital | 6.23M |
Cash Flow
In the last 12 months, operating cash flow was -7.31M and capital expenditures -17.00K, giving a free cash flow of -7.33M.
| Operating Cash Flow | -7.31M |
| Capital Expenditures | -17.00K |
| Free Cash Flow | -7.33M |
| FCF Per Share | -0.25 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -11.48% |
| FCF Yield | -7.37% |
Analyst Forecast
The average price target for ENTX is $10, which is 270.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $10 |
| Price Target Difference | 270.4% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 14.74 |
| Piotroski F-Score | 3 |